Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort
Source check: Source checked. Not independent scientific confirmation.
Finding: In a cohort of 410 treatment-naïve Mexican participants, random-forest microbiome models classified T2D and prediabetes versus normoglycemia and identified candidate taxa associated with each group. This is cross-sectional association, not causal evidence of disease progression or a validated diagnostic. Cohort stratification and comparative model performance reported; cross-sectional cohort and association-only interpretation retained.
Technology: Six ML models compare 16S rRNA microbiome profiles; random forest ranks taxa for glycemic-group classification.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Six ML models compare 16S rRNA microbiome profiles; random forest ranks taxa for glycemic-group classification.
- Test and result
- In a cohort of 410 treatment-naïve Mexican participants, random-forest microbiome models classified T2D and prediabetes versus normoglycemia and identified candidate taxa associated with each group. This is cross-sectional association, not causal evidence of disease progression or a validated diagnostic.
- Limitation / still unknown
- Cohort stratification and comparative model performance reported; cross-sectional cohort and association-only interpretation retained. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1170459/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.